About My Book
|Title of the Book||
Heart Failure: What a Non-Heart Failure Specialist Needs to Know
PIEDMONT HEART INSTITUTE
Dr. Yehya is an advanced heart failure, mechanical circulatory support and heart transplant Cardiologist at Piedmont Heart Institute. Prior to joining Piedmont Heart, he completed his Advanced Heart Failure and Transplantation fellowship at Stanford University. He completed his Internal Medicine residency at Emory University and his Cardiovascular Diseases fellowship at the Medical College of Georgia. Dr. Yehya earned his Master’s Degree in Biochemistry and his Medical Degree from the American University of Beirut in Lebanon. Dr. Yehya is board certified in Internal Medicine, Cardiovascular Diseases, Advanced Heart Failure and Heart Transplant Cardiology, Echocardiography, and Nuclear Cardiology. Dr. Yehyais is a Fellow of the American College of Cardiology, and a council member in Clinical Cardiology at the American Heart Association. He is an active member of numerous professional societies including: the Heart Failure Society of America, the International Society for Heart and Lung Transplantation, and Alpha-Omega-Alpha honor medical society. Dr. Yehya has published in peer-reviewed journals and has presented his work in regional and national conferences.His specialties include advanced heart failure, heart transplantation, pulmonary hypertension, cardiomyopathy and mechanical circulatory support.
|Associations, Organizations, Colleges, Universities, Libraries, Bookstores to Market the Book||
HEART FAILURE SOCIETY OF AMERICA (HFSA ANNUAL MEETING)
|Description of the Book that can be Used in a Scholarly or Scientific Journal||
Approaches to and therapy for many cardiovascular disorders have changed greatly over the past several decades, but perhaps none have changed so greatly as the understanding of and therapy for heart failure. Advances have occurred in the understanding of the varying physiology for this clinical syndrome, including pharmacologic therapy, device therapy, and therapy for truly advanced stages of the syndrome. Future developments may well involve gene or stem cell therapy. Clinical trials continue to define the roles of newer approaches. Clearly, this highly prevalent syndrome and the evolution of its clinical appreciation and treatment have become too extensive; it is a rapidly evolving subject that until now has not been adequately covered in a standard medical textbook.
|For Whom the Book is Written||
GENERAL CARDIOLOGISTS, CARDIOLOGY FELLOWS, INTERNAL MEDICINE DOCTORS, RESIDENTS IN TRAINING, PRIMARY CARE PHYSICIANS, EMERGENCY ROOM PHYSICIANS, NURSE PRACTITIONERS, PHYSICIAN ASSISTANTS